Private equity firm TPG Capital Asia is considering selling a 20% stake in Pathology Asia Holdings, its pathology portfolio in the region, ahead of the unit’s initial public offering (IPO), according to a Bloomberg report.
Register now to enjoy 3 free articles per month,
or log in to continue reading.
Stay informed with complimentary articles each month
Gain access to our exclusive newsletters delivered directly to your inbox
Be the first to know about all our summits!
Already a Subscriber? Log in
